Gregory T. Went,Timothy J. Fultz,Laurence R. Meyerson
申请号：
US13536525
公开号：
US20120264829A1
申请日:
2012.06.28
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention provides methods for administering memantine to a subject. Memantine in an extended release form containing 22.5 to 30 mg memantine or a pharmaceutically acceptable salt is administered to a patient suffering from a neurological condition, such as Alzheimers disease, Parkinsons disease or dementia. The extended release form achieves particular pharmacokinetic criteria such as change in plasma concentration of memantine over time and ratio of maximum memantine plasma concentration to mean memantine plasma concentration.
